Bloomlife is a Lanza techVentures portfolio company with a business proposition unlike any of the more traditional companies in the portfolio. Instead of products so far down the semiconductor supply chain that they are hard to explain to consumers, Bloomlife is building a medical device targeting expectant mothers and their partners.
The product, a home-monitoring device used by women in the last trimester of their pregnancy, has the potential to support OBGYN in detecting pre-term labor, heartbeat and other indications of fetal health. When asked why what attracted him to Bloomlife, Lucio Lanza, Lanza techVentures’ Managing Partner, quickly answered, “It gives women peace of mind. It connects the mother to the baby, one of the key motivators for the investment.” A product like this enables moms to have a connection to the baby and to give them a way to take charge of their pregnancies, he added.